Article

Outcomes of a 12-month web-based intervention for overweight and obese men.

Department of Family and Preventive Medicine, University of California, La Jolla, San Diego, USA.
Annals of Behavioral Medicine (impact factor: 4.2). 08/2011; 42(3):391-401. DOI:10.1007/s12160-011-9296-7 pp.391-401
Source: PubMed

ABSTRACT This study assessed the effect of a 1-year internet-based weight loss intervention for men.
Four hundred forty-one overweight and obese men were randomized to intervention or delayed treatment. Participants completed a Web-based assessment of diet and physical activity behaviors and weekly tailored Web modules addressing weight-related behaviors.
At 12 months compared to controls, intervention men decreased percent of energy from saturated fat and increased grams of fiber and fruit/vegetable servings per 1.000 kcal (p values < 0.001) and walked 16 min more per day (p < 0.05). No between-group differences in body mass index (BMI), weight, or waist circumference were seen, but among completers, men in the highest tertile of intervention participation had lower weight (98.74 vs. 102.37 kg), BMI (32.38 vs. 33.46), and waist circumference (42.17 vs. 43.47 cm) compared to men who participated less often.
The intervention improved diet and activity behaviors, but weight loss occurred only for those with the highest adherence.

0 0
 · 
2 Bookmarks
 · 
86 Views
  • Article: Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
    [show abstract] [hide abstract]
    ABSTRACT: The successful management of obesity requires a long-term approach that is tailored to an individual's lifestyle and needs. Initial treatment should focus on lifestyle modifications-dietary interventions and increased physical activity-with behavioral modification strategies used adjunctively. Several antiobesity drugs are approved by the Food and Drug Administration for use in obese patients, as well as in overweight individuals with at least one obesity-related comorbidity. Most are approved only for short-term weight loss, but sibutramine and orlistat are approved for long-term weight loss and maintenance. In addition to weight reduction, in clinical trials these drugs provided beneficial actions on several cardiovascular risk factors. Several other drugs currently approved for other uses show promise in their ability to cause weight loss. Surgical options should be reserved for severely obese patients with significant medical comorbidities or physical conditions.
    Obesity research 01/2003; 10 Suppl 2:116S-123S. · 4.95 Impact Factor
  • Source
    Article: What predicts weight regain in a group of successful weight losers? .
    [show abstract] [hide abstract]
    ABSTRACT: This study identified predictors of weight gain versus continued maintenance among individuals already successful at long-term weight loss. Weight, behavior, and psychological information was collected on entry into the study and 1 year later. Thirty-five percent gained weight over the year of follow-up, and 59% maintained their weight losses. Risk factors for weight regain included more recent weight losses (less than 2 years vs. 2 years or more), larger weight losses (greater than 30% of maximum weight vs. less than 30%), and higher levels of depression, dietary disinhibition, and binge eating levels at entry into the registry. Over the year of follow-up, gainers reported greater decreases in energy expenditure and greater increases in percentage of calories from fat. Gainers also reported greater decreases in restraint and increases in hunger, dietary disinhibition, and binge eating. This study suggests that several years of successful weight maintenance increase the probability of future weight maintenance and that weight regain is due at least in part to failure to maintain behavior changes.
    Journal of Consulting and Clinical Psychology 05/1999; 67(2):177-85. · 4.85 Impact Factor
  • Source
    Article: Systematic review: an evaluation of major commercial weight loss programs in the United States.
    [show abstract] [hide abstract]
    ABSTRACT: Each year millions of Americans enroll in commercial and self-help weight loss programs. Health care providers and their obese patients know little about these programs because of the absence of systematic reviews. To describe the components, costs, and efficacy of the major commercial and organized self-help weight loss programs in the United States that provide structured in-person or online counseling. Review of company Web sites, telephone discussion with company representatives, and search of the MEDLINE database. Randomized trials at least 12 weeks in duration that enrolled only adults and assessed interventions as they are usually provided to the public, or case series that met these criteria, stated the number of enrollees, and included a follow-up evaluation that lasted 1 year or longer. Data were extracted on study design, attrition, weight loss, duration of follow-up, and maintenance of weight loss. We found studies of eDiets.com, Health Management Resources, Take Off Pounds Sensibly, OPTIFAST, and Weight Watchers. Of 3 randomized, controlled trials of Weight Watchers, the largest reported a loss of 3.2% of initial weight at 2 years. One randomized trial and several case series of medically supervised very-low-calorie diet programs found that patients who completed treatment lost approximately 15% to 25% of initial weight. These programs were associated with high costs, high attrition rates, and a high probability of regaining 50% or more of lost weight in 1 to 2 years. Commercial interventions available over the Internet and organized self-help programs produced minimal weight loss. Because many studies did not control for high attrition rates, the reported results are probably a best-case scenario. With the exception of 1 trial of Weight Watchers, the evidence to support the use of the major commercial and self-help weight loss programs is suboptimal. Controlled trials are needed to assess the efficacy and cost-effectiveness of these interventions.
    Annals of internal medicine 02/2005; 142(1):56-66. · 16.73 Impact Factor

Full-text

View
17 Downloads
Available from
5 Sep 2012

Keywords

12 months
 
activity behaviors
 
between-group differences
 
body mass index
 
completers
 
fruit/vegetable servings
 
grams
 
highest adherence
 
intervention participation
 
obese men
 
p values
 
Participants
 
physical activity behaviors
 
waist circumference
 
Web-based assessment
 
weekly tailored Web modules
 
weight-related behaviors